Genincode PLC (LON:GENI)
1.05p
Spriggl Score: Moderate— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Shares trebled via deep-discount fundraising; FDA approval remains the only route to meaningful recovery.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Genincode PLC
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology offers patients and physicians with preventative care and treatm…
- Sector:
- Healthcare
- Industry:
- Diagnostics & Research
- Market Cap:
- £7.8M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Genincode PLC and 1,600+ UK and US stocks.
Start free